Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
MERS
Vaccines
Vaccines alliance hands J&J, Oxford $14.6M for MERS work
In its latest development deal, the outbreak readiness group CEPI has awarded J&J and Oxford University $14.6 million for work on a MERS vaccine.
Eric Sagonowsky
Sep 27, 2018 9:26am
CEPI awards IDT Biologika up to $36M for MERS research
Aug 21, 2018 11:10am
FiercePharmaAsia—Sanofi, Takeda, I-Mab and more
Jul 6, 2018 9:13am
Inovio and GeneOne's MERS vaccine shows promise in phase 1
Jul 3, 2018 9:25am
Inovio's MERS vaccine, Inimmune and more—News of Note
Jun 27, 2018 8:55am
Inovio nets $56M CEPI grant for Lassa fever and MERS vaccines
Apr 11, 2018 11:10am
